Pharmaceuticals, Biotechnology and Life Sciences
HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing…
– AEON confirmed that earlier today it held its BPD Type 2a Meeting with the FDA, in line with prior guidance,…
CONSHOHOCKEN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics…
BRISBANE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company with a…
Vancouver, Canada, Jan. 20, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…
EMERYVILLE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company…
SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on…
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today…
Chassieu, Jan. 20, 2026 (GLOBE NEWSWIRE) — Chassieu (France), 20 January 2026 – 6:00 pm – Amoéba (FR0011051598 – ALMIB),…
FORT LAUDERDALE, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM) (“Protext” “TXTM” or the “Company”) is…